LeadIQ logo
Learn more at LeadIQ.com

Insights

Lead Drug Candidate Partnership Destiny Pharma partnered with Sebela Pharmaceuticals for its NTCD-M3 program in a deal potentially worth up to $570 million plus royalties. This collaboration presents a significant sales opportunity for both companies in the biotechnology space.

Market Expansion through Licensing Partners Destiny Pharma hired Mark Smith and Stephen Cork as licensing partners, aiming to secure partnerships for their lead drug candidate XF-73 nasal gel. This strategic move signals a push for market expansion and increased sales avenues.

Diversification and Global Reach Partnering with China Medical Systems to develop a dermal formulation of XR-73 for skin infections showcases Destiny Pharma's diversification strategy. This collaboration opens doors for global sales opportunities and the potential to penetrate new markets.

Change in Executive Leadership With the appointment of a new CEO, Destiny Pharma signals a shift in leadership strategies. Sales professionals can leverage this change to build new relationships and explore fresh avenues for partnerships and business growth.

Strategic Chairman Appointment Hiring Nigel Rudd as chairman brings valuable industry expertise to Destiny Pharma. Sales teams can capitalize on this strategic move to enhance credibility, build partnerships, and explore new sales channels under Rudd's leadership.

Similar companies to Destiny Pharma plc

Destiny Pharma plc Tech Stack

Destiny Pharma plc uses 8 technology products and services including WordPress, jQuery Migrate, HTTP/3, and more. Explore Destiny Pharma plc's tech stack below.

  • WordPress
    Content Management System
  • jQuery Migrate
    Javascript Libraries
  • HTTP/3
    Miscellaneous
  • RSS
    Miscellaneous
  • Open Graph
    Miscellaneous
  • Formidable Form
    Web Platform Extensions
  • LiteSpeed
    Web Servers
  • Apache HTTP Server
    Web Servers

Media & News

Destiny Pharma plc's Email Address Formats

Destiny Pharma plc uses at least 1 format(s):
Destiny Pharma plc Email FormatsExamplePercentage
First.Last@destinypharma.comJohn.Doe@destinypharma.com
43%
FL@destinypharma.comJD@destinypharma.com
30%
FLast@destinypharma.comJDoe@destinypharma.com
13%
First@destinypharma.comJohn@destinypharma.com
14%

Frequently Asked Questions

Where is Destiny Pharma plc's headquarters located?

Minus sign iconPlus sign icon
Destiny Pharma plc's main headquarters is located at Sussex Innovation Centre Science Park square Brighton, GB. The company has employees across 4 continents, including EuropeAfricaAsia.

What is Destiny Pharma plc's phone number?

Minus sign iconPlus sign icon
You can contact Destiny Pharma plc's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Destiny Pharma plc's official website and social media links?

Minus sign iconPlus sign icon
Destiny Pharma plc's official website is destinypharma.com and has social profiles on LinkedIn.

How much revenue does Destiny Pharma plc generate?

Minus sign iconPlus sign icon
As of July 2024, Destiny Pharma plc's annual revenue reached $3.8M.

What is Destiny Pharma plc's SIC code NAICS code?

Minus sign iconPlus sign icon
Destiny Pharma plc's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Destiny Pharma plc have currently?

Minus sign iconPlus sign icon
As of July 2024, Destiny Pharma plc has approximately 27 employees across 4 continents, including EuropeAfricaAsia. Key team members include Chief Executive Officer: C. T.Chief Medical Officer: J. G. M.Vice President Pharmaceutical Development: S. A.. Explore Destiny Pharma plc's employee directory with LeadIQ.

What industry does Destiny Pharma plc belong to?

Minus sign iconPlus sign icon
Destiny Pharma plc operates in the Biotechnology Research industry.

What technology does Destiny Pharma plc use?

Minus sign iconPlus sign icon
Destiny Pharma plc's tech stack includes WordPressjQuery MigrateHTTP/3RSSOpen GraphFormidable FormLiteSpeedApache HTTP Server.

What is Destiny Pharma plc's email format?

Minus sign iconPlus sign icon
Destiny Pharma plc's email format typically follows the pattern of . Find more Destiny Pharma plc email formats with LeadIQ.

How much funding has Destiny Pharma plc raised to date?

Minus sign iconPlus sign icon
As of July 2024, Destiny Pharma plc has raised $8.9M in funding. The last funding round occurred on Mar 16, 2023 for $8.9M.

When was Destiny Pharma plc founded?

Minus sign iconPlus sign icon
Destiny Pharma plc was founded in 1997.
Destiny Pharma plc

Destiny Pharma plc

Biotechnology ResearchBrighton, United Kingdom11-50 Employees

Destiny Pharma is a clinical stage, innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections. Its pipeline has novel microbiome-based biotherapeutics and XF drug clinical assets including NTCD-M3, a Phase 3 ready treatment for the prevention of C. difficile infection (CDI) recurrence which is the leading cause of hospital acquired infection in the US and also XF-73 nasal gel, which has recently completed a positive Phase 2b clinical trial targeting the prevention of post-surgical staphylococcal hospital infections including MRSA. It is also co-developing SPOR-COVTM, a novel, biotherapeutic product for the prevention of COVID-19 and other viral respiratory infections and has earlier grant funded XF drug research projects.

For further information on the company, please visit www.destinypharma.com

Section iconCompany Overview

Headquarters
Sussex Innovation Centre Science Park square Brighton, GB
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1997
Employees
11-50

Section iconFunding & Financials

  • $8.9M

    Destiny Pharma plc has raised a total of $8.9M of funding over 7 rounds. Their latest funding round was raised on Mar 16, 2023 in the amount of $8.9M.

  • $10M

    Destiny Pharma plc's revenue is in the range of $10M

Section iconFunding & Financials

  • $8.9M

    Destiny Pharma plc has raised a total of $8.9M of funding over 7 rounds. Their latest funding round was raised on Mar 16, 2023 in the amount of $8.9M.

  • $10M

    Destiny Pharma plc's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.